Log in

Relevant bibliographies by topics / Translocation renal cell carcinoma / Journal articles

To see the other types of publications on this topic, follow the link: Translocation renal cell carcinoma.

Journal articles on the topic 'Translocation renal cell carcinoma'

Author: Grafiati

Published: 11 March 2023

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Translocation renal cell carcinoma.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Armah, Henry B., and Anil V. Parwani. "Xp11.2 Translocation Renal Cell Carcinoma." Archives of Pathology & Laboratory Medicine 134, no. 1 (2010): 124–29. http://dx.doi.org/10.5858/2008-0391-rsr.1.

Full text

Abstract:

Abstract Xp11.2 translocation renal cell carcinomas (RCCs), a recently recognized distinct subtype, are rare tumors predominantly reported in young patients. They comprise at least one-third of pediatric RCCs, and only few adult cases have been reported. They are characterized by various translocations involving chromosome Xp11.2, all resulting in gene fusions involving the transcription factor E3 (TFE3) gene. In recent years, at least 6 different Xp11.2 translocation RCCs have been identified and characterized at the molecular level. These include a distinctive RCC that bears a translocation

APA, Harvard, Vancouver, ISO, and other styles

2

Geller, James I., Pedram Argani, Adebowale Adeniran, et al. "Translocation renal cell carcinoma." Cancer 112, no. 7 (2008): 1607–16. http://dx.doi.org/10.1002/cncr.23331.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Caliò, Anna, Diego Segala, Enrico Munari, Matteo Brunelli, and Guido Martignoni. "MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge." Cancers 11, no. 8 (2019): 1110. http://dx.doi.org/10.3390/cancers11081110.

Full text

Abstract:

The new category of MiT family translocation renal cell carcinoma has been included into the World Health Organization (WHO) classification in 2016. The MiT family translocation renal cell carcinoma comprises Xp11 translocation renal cell carcinoma harboring TFE3 gene fusions and t(6;11) renal cell carcinoma harboring TFEB gene fusion. At the beginning, they were recognized in childhood; nevertheless, it has been demonstrated that these neoplasms can occur in adults as well. In the nineties, among Xp11 renal cell carcinoma, ASPL, PRCC, and SFPQ (PSF) were the first genes recognized as partners

APA, Harvard, Vancouver, ISO, and other styles

4

Kothari, KanchanS, PragatiA Sathe, LeenaP Naik, and BhuvaneshwariM Kandalkar. "Xp11 translocation renal cell carcinoma." Indian Journal of Pathology and Microbiology 56, no. 4 (2013): 471. http://dx.doi.org/10.4103/0377-4929.125383.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Neagu, O., A. Petrescu, G. Berdan, et al. "Xp11.2 translocation renal cell carcinoma." European Urology Supplements 17, no. 12 (2018): e2694. http://dx.doi.org/10.1016/s1569-9056(18)33533-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Ross, Hillary, and Pedram Argani. "Xp11 translocation renal cell carcinoma." Pathology 42, no. 4 (2010): 369–73. http://dx.doi.org/10.3109/00313021003767348.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ross, Hillary, Morris Edelman, and Pedram Argani. "Xp11 Translocation Renal Cell Carcinoma." Pathology Case Reviews 15, no. 1 (2010): 3–6. http://dx.doi.org/10.1097/pcr.0b013e3181d2cfc2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

de Oliveira, C. V. L., G. R. Bechara, S. R. Zacchi, M. C. L. de Miranda, G. Z. Pinho, and M. M. L. de Miranda. "MiT family translocation renal cell carcinoma." Journal of Pediatric Surgery Case Reports 45 (June 2019): 101190. http://dx.doi.org/10.1016/j.epsc.2019.101190.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Argani, Pedram. "MiT family translocation renal cell carcinoma." Seminars in Diagnostic Pathology 32, no. 2 (2015): 103–13. http://dx.doi.org/10.1053/j.semdp.2015.02.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Torous, Vanda Farahmand, Albert Su, David Y. Lu, and Sarah M. Dry. "Adult Patient with Synchronous Gastrointestinal Stromal Tumor and Xp11 Translocation-Associated Renal Cell Carcinoma: A Unique Case Presentation with Discussion and Review of Literature." Case Reports in Urology 2015 (2015): 1–6. http://dx.doi.org/10.1155/2015/814809.

Full text

Abstract:

Gastrointestinal stromal tumor (GIST) is the most common primary mesenchymal tumor of the gastrointestinal tract. This entity comprises a wide spectrum of tumors that vary from benign to overtly malignant, with the majority of these tumors harboring oncogenic mutations of the KIT receptor tyrosine kinase that can aid in diagnosis as well as in targeted therapy. Although the majority of GISTs are sporadic, there are forms that are associated with a variety of syndromes including Carney-Stratakis syndrome and neurofibromatosis type 1, as well as a subset of familial GIST syndromes that are cause

APA, Harvard, Vancouver, ISO, and other styles

11

Bambury, Richard Martin, Claire Brady, Aoife McCarthy, Stewart Fleming, Nicholas J. Mayer, and Derek Gerard Power. "Translocation renal cell carcinomas: An evolving entity." Journal of Clinical Oncology 30, no. 5_suppl (2012): 472. http://dx.doi.org/10.1200/jco.2012.30.5_suppl.472.

Full text

Abstract:

472 Background: Translocation renal cell carcinomas (RCCs) are a novel, rare and distinct clinicopathological entity. The term refers to RCCs with overexpression of transcription factor E3 (TFE3) due to translocation involving the Xp11 locus or less commonly with overexpression of transcription factor EB (TFEB) due to a t(6:11) translocation. In children it is estimated that these tumours account for 40% of RCCs but in adults this proportion is estimated to be 1-4%. As these neoplasms are only recently recognised, outcome data are premature. We report 2 cases of translocation RCC in an Irish r

APA, Harvard, Vancouver, ISO, and other styles

12

Ellati, Riyad T., Ibrahim Abukhiran, Kholoud Alqasem, et al. "Clinicopathologic Features of Translocation Renal Cell Carcinoma." Clinical Genitourinary Cancer 15, no. 1 (2017): 112–16. http://dx.doi.org/10.1016/j.clgc.2016.05.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Malouf, Gabriel G., Federico A. Monzon, Jérôme Couturier, et al. "Genomic Heterogeneity of Translocation Renal Cell Carcinoma." Clinical Cancer Research 19, no. 17 (2013): 4673–84. http://dx.doi.org/10.1158/1078-0432.ccr-12-3825.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Zhao, Jianping, and Eduardo Eyzaguirre. "Clear Cell Papillary Renal Cell Carcinoma." Archives of Pathology & Laboratory Medicine 143, no. 9 (2019): 1154–58. http://dx.doi.org/10.5858/arpa.2018-0121-rs.

Full text

Abstract:

Clear cell papillary renal cell carcinoma (ccpRCC) is a recently recognized entity and represents the fourth most common variant of renal cell carcinoma (RCC). It has unique morphologic and immunohistochemical features and demonstrates an indolent clinical behavior. Microscopically, it may mimic other RCCs with clear cell features, such as clear cell RCC, translocation RCC, and papillary RCC with clear cell changes. A high index of suspicion is required to keep ccpRCC in the differential diagnosis of RCCs with features of clear cell and/or papillary architecture. In equivocal cases, immunohist

APA, Harvard, Vancouver, ISO, and other styles

15

Martin, Elizabeth E., Rohit Mehra, Colleen Jackson-Cook, and Steven Christopher Smith. "Renal Cell Carcinoma With TFEB Translocation Versus Unclassified Renal Cell Carcinoma With TFEB Amplification." AJSP: Reviews and Reports 22, no. 6 (2017): 305–12. http://dx.doi.org/10.1097/pcr.0000000000000214.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Cutruzzula, Paulette, David Cahn, Dana Kivlin, Carmen Tong, Daniel Edwards, and Melanie Amster. "A Review of Translocation T(6;11) Renal Cell Carcinoma Tumors in the Adult Patient." Current Urology 10, no. 2 (2016): 69–71. http://dx.doi.org/10.1159/000447154.

Full text

Abstract:

Historically, T(6;11) renal cell carcinoma (RCC) has been associated with the pediatric and adolescent populations and documentation of this tumor in adults has been rare. However, the frequency of translocation renal cell carcinoma (TRCC) may be widely underestimated in the adult population due to an inadequate immunohistochemical workup or misdiagnosis from similar gross and histological findings to other RCC. A subset of MiT family translocation carcinomas, t(6:11) (p21;q12) translocation tumors cause an alpha-TFEB gene fusion. Morphologically, this neoplasm tends to mimic the various types

APA, Harvard, Vancouver, ISO, and other styles

17

Dorobantu-Lungu, Luiza-Roxana, Viviana Dinca, Andrei Gegiu, et al. "The Relevance of the Virchow Node and Virchow Triad in Renal Cancer Diagnosis." Clinics and Practice 15, no. 1 (2025): 18. https://doi.org/10.3390/clinpract15010018.

Full text

Abstract:

Background: The purpose of this article is to overview the clinical significance of left supraclavicular adenopathy and review the etiology of inferior vena cava (IVC) thrombosis, starting from a presentation of a rare case of renal cell carcinoma (RCCs) with Xp11.2 translocation involving TFE3 gene fusion. This article also aims to review the literature to understand the characteristics of this rare type of renal tumor. Renal cell carcinoma (RCC) associated with Xp11.2 translocation/gene fusion TFE3 is a rare subtype of kidney cancer that was classified in 2016 as belonging to the family of r

APA, Harvard, Vancouver, ISO, and other styles

18

Taşkınlar, Hakan, Dinçer Avlan, Çağlar Çıtak, Ayşe Polat, and Ali Naycı. "A rare cause of childhood renal cysts: Xp11.2 translocation renal cell carcinoma." Canadian Urological Association Journal 9, no. 1-2 (2015): 36. http://dx.doi.org/10.5489/cuaj.2321.

Full text

Abstract:

Pediatric renal cysts are rare, usually asymptomatic and incidentally detected in children. Cyst associated renal cell carcinoma (RCC) or cystic RCC is extremely rare in children. Bosniak classification system has been accepted for the management of cystic renal masses. Xp11.2 translocation RCC is a recently classified distinct subtype and usually affects children and adolescents. We report the case of a 10-year-old girl with Xp11.2 translocation RCC from a cyst of the right kidney.

APA, Harvard, Vancouver, ISO, and other styles

19

Chan, Susanne M., Christopher G. Sherman, Manal Y. Gabril, et al. "Xp11.2 translocations in adult renal cell carcinomas with clear cell and papillary features." Journal of Clinical Oncology 30, no. 15_suppl (2012): 4613. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.4613.

Full text

Abstract:

4613 Background: Xp11.2 translocation renal cell carcinoma (RCC) is a rare tumor with unpredictable clinical course and prognosis in adults. Recognition of these tumors depends on the identification of a RCC with unique histology, particularly clear cell and papillary (CCP) features. Our objectives were to determine the incidence of Xp11.2 translocations in adult RCCs with clear cell and papillary features, and to characterize the clinicopathological features and prognosis of adult Xp11.2 RCCs. Methods: Slides for 1047 RCCs in adults (1999-2009) were retrieved from multiple institutions. Cases

APA, Harvard, Vancouver, ISO, and other styles

20

Al-Daghmin, Ali, Sohaib Alhamss, Khloud Al-qasem, et al. "Patterns of management of translocation renal cell carcinoma." Türk Üroloji Dergisi/Turkish Journal of Urology 44, no. 6 (2018): 467–72. http://dx.doi.org/10.5152/tud.2018.40460.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Lim, Bumjin, Dalsan You, In Gab Jeong, et al. "Clinicopathological features of Xp11.2 translocation renal cell carcinoma." Korean Journal of Urology 56, no. 3 (2015): 212. http://dx.doi.org/10.4111/kju.2015.56.3.212.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Sureka, Binit, Kalpana Bansal, and Ankur Arora. "Imaging hallmark of Xp11.2 translocation renal cell carcinoma." Canadian Urological Association Journal 9, no. 7-8 (2015): 572. http://dx.doi.org/10.5489/cuaj.2817.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Sano, Yuho, Ryuta Tanimoto, Katsumi Sasaki, Satoko Nakamura, Koichi Mizobuchi, and Naoto Kuroda. "6p21 translocation renal cell carcinoma: A case report." Urology Case Reports 34 (January 2021): 101470. http://dx.doi.org/10.1016/j.eucr.2020.101470.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Jeong, Chang Wook, Jae So Cho, Moses Lee, et al. "Comprehensive genetic characterization of TFE3-positive renal cell carcinoma." Journal of Clinical Oncology 36, no. 6_suppl (2018): 635. http://dx.doi.org/10.1200/jco.2018.36.6_suppl.635.

Full text

Abstract:

635 Background: MiT family translocation renal cell carcinoma (RCC) is very rare variant which has translocation of Xp11.2/TFE3 gene or t(6;11)/TFEB gene. Xp11.2 translocation RCC is predominantly reported in younger age and has aggressive features. However, its pathophysiology or genetic characteristics are rarely understood. The aim of the study is to describe the comprehensive genetic characteristics of TFE3-positive RCC diagnosed by immunohistochemistry. Methods: We identified patients who were clinically diagnosed as Xp11.2 translocation RCC by immunostaining positive of TFE3 from two ter

APA, Harvard, Vancouver, ISO, and other styles

25

Power, Derek Gerard, Jodie E. Battley, Aoife McCarthy, et al. "Translocation renal cell carcinomas: An evolving entity." Journal of Clinical Oncology 30, no. 15_suppl (2012): e15078-e15078. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e15078.

Full text

Abstract:

e15078 Background: Translocation renal cell carcinomas (tRCCs) are a novel, rare and distinct clinicopathological entity. The term refers to RCCs with overexpression of transcription factor E3 (TFE3) due to translocation involving the Xp11 locus or less commonly with overexpression of transcription factor EB (TFEB) due to a t(6:11) translocation. In children it is estimated that these tumours account for 40% of RCCs but in adults this proportion is estimated to be 1-4%. These neoplasms are only recently recognised and outcome data are premature. We report 2 cases of tRCC in an Irish regional c

APA, Harvard, Vancouver, ISO, and other styles

26

Dey, Biswajit, Bhawana Badhe, Krishna Kumar Govindarajan, and Ranjith Arumbakkam Ramesh. "Xp11.2 Translocation Renal Cell Carcinoma Diagnosed by Immunohistochemistry and Cytogenetics." Journal of Laboratory Physicians 8, no. 02 (2016): 123–25. http://dx.doi.org/10.4103/0974-2727.180796.

Full text

Abstract:

ABSTRACTXp11.2 translocation renal cell carcinomas (TRCCs) are a group of neoplasms with distinct clinical, histopathological appearance, immunohistochemical, and cytogenetic profile. We report a case of Xp11.2 translocation TRCC in an 11-year-old male diagnosed based on immunohistochemistry and fluorescence in situ hybridization.

APA, Harvard, Vancouver, ISO, and other styles

27

Webster, Bradley R., Nikhil Gopal, and Mark W. Ball. "Tumorigenesis Mechanisms Found in Hereditary Renal Cell Carcinoma: A Review." Genes 13, no. 11 (2022): 2122. http://dx.doi.org/10.3390/genes13112122.

Full text

Abstract:

Renal cell carcinoma is a heterogenous cancer composed of an increasing number of unique subtypes each with their own cellular and tumor behavior. The study of hereditary renal cell carcinoma, which composes just 5% of all types of tumor cases, has allowed for the elucidation of subtype-specific tumorigenesis mechanisms that can also be applied to their sporadic counterparts. This review will focus on the major forms of hereditary renal cell carcinoma and the genetic alterations contributing to their tumorigenesis, including von Hippel Lindau syndrome, Hereditary Papillary Renal Cell Carcinoma

APA, Harvard, Vancouver, ISO, and other styles

28

Vento, Joseph, Tian Zhang, Payal Kapur, Hans Hammers, James Brugarolas, and Qian Qin. "Systemic Treatment of Locally Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma." Cancers 17, no. 9 (2025): 1527. https://doi.org/10.3390/cancers17091527.

Full text

Abstract:

Non-clear cell renal cell carcinoma (nccRCC) represents a heterogenous group of malignancies with varying degrees of clinical aggressiveness and response to different systemic therapies. As the characterization of subtypes of nccRCC continues to evolve, it is important to understand the evidence around systemic treatments used in advanced or metastatic stages of specific subtypes. Here, we review the literature on systemic therapies in nccRCC, with a focus on prospective trials that included patients with papillary renal cell carcinoma (RCC), chromophobe RCC, RCC not further classified/unclass

APA, Harvard, Vancouver, ISO, and other styles

29

Petrinec, Benjamin, Bryan Morales Vargas, Lara R. Harik, and Viraj A. Master. "Renal Cancer Without Primary Cancer in the Kidney: Extra-Renal TFE3 Translocation Associated Renal Cell Carcinoma." Kidney Cancer 5, no. 2 (2021): 107–12. http://dx.doi.org/10.3233/kca-200102.

Full text

Abstract:

We report a case of an isolated para-aortic retroperitoneal renal cell carcinoma (RCC) in the absence of a primary cancer in the kidney. Single case reports in the literature have described extra-renal RCC in different locations with no evidence of primary renal tumor. We present the initial presentation, diagnostic imaging, surgical treatment, and pathologic evaluation. Immunohistochemistry demonstrated positivity for TFE3 and TFEB, both of which are Microphthalmia associated transcription factors (MiT) associated with translocation RCCs. We hypothesize these few cases of extra-renal RCC repr

APA, Harvard, Vancouver, ISO, and other styles

30

Parihar, Asmita, Satish K. Tickoo, Sunil Kumar, and Vinod Kumar Arora. "Xp11 Translocation Renal Cell Carcinoma Morphologically Mimicking Clear Cell–Papillary Renal Cell Carcinoma in an Adult Patient." International Journal of Surgical Pathology 23, no. 3 (2014): 234–37. http://dx.doi.org/10.1177/1066896914562280.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Yan, Benjamin C., A. Craig Mackinnon, and Hikmat A. Al-Ahmadie. "Recent Developments in the Pathology of Renal Tumors: Morphology and Molecular Characteristics of Select Entities." Archives of Pathology & Laboratory Medicine 133, no. 7 (2009): 1026–32. http://dx.doi.org/10.5858/133.7.1026.

Full text

Abstract:

Abstract Context.—Renal cell carcinoma is a heterogeneous group of tumors with distinct histopathologic features, molecular characteristics, and clinical outcome. These tumors can be sporadic as well as familial or associated with syndromes. The genetic abnormalities underlying these syndromes have been identified and were subsequently found in corresponding sporadic renal tumors. Objective.—To review the recent molecular and genetic advancements relating to sporadic and familial renal carcinomas as well as those related to Xp11.2 translocation– associated renal cell carcinoma and renal medull

APA, Harvard, Vancouver, ISO, and other styles

32

Banerjee, Soirindhri, Souvik Paul, and Aloke Ghosh Dastidar. "Clear cell variant of pediatric renal cell carcinoma: Rare and challenging." Journal of Cancer Research and Therapeutics 19, no. 5 (2023): 1443–46. http://dx.doi.org/10.4103/jcrt.jcrt_540_21.

Full text

Abstract:

ABSTRACT We report a very rare case of clear cell variant of renal cell carcinoma (RCC) in a 3-year-old male child, who presented to us with a left-sided lump in his abdomen. Computed tomography (CT) scan and technetium-99 Dimercapto succinic acid (DMSA) scan revealed a large left renal mass with compromised left renal function. Left-sided nephroureterectomy was done and histopathology demonstrated clear cell carcinoma, possibly translocation-associated RCC (miT family) staged as pT2NxMx. Postoperative CT scans of the thorax and whole abdomen showed secondaries in the lungs and liver. We discu

APA, Harvard, Vancouver, ISO, and other styles

33

Williamson, Sean R., Leonardo Cardili, Lisa J. Whiteley, Jessica Sanchez, and Olena Kis. "Sclerosing TSC1 mutated renal cell carcinoma: An unusual pattern mimicking MITF family translocation renal cell carcinoma." Genes, Chromosomes and Cancer 59, no. 10 (2020): 591–94. http://dx.doi.org/10.1002/gcc.22860.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Gemmill, Robert M., James D. West, Ferenc Boldog, et al. "The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8." Proceedings of the National Academy of Sciences 95, no. 16 (1998): 9572–77. http://dx.doi.org/10.1073/pnas.95.16.9572.

Full text

Abstract:

The 3;8 chromosomal translocation, t(3;8)(p14.2;q24.1), was described in a family with classical features of hereditary renal cell carcinoma. Previous studies demonstrated that the 3p14.2 breakpoint interrupts the fragile histidine triad gene (FHIT) in its 5′ noncoding region. However, evidence that FHIT is causally related to renal or other malignancies is controversial. We now show that the 8q24.1 breakpoint region encodes a 664-aa multiple membrane spanning protein, TRC8, with similarity to the hereditary basal cell carcinoma/segment polarity gene, patched. This similarity involves two regi

APA, Harvard, Vancouver, ISO, and other styles

35

Owari, Takuya, Takamitsu Sasaki, Kiyomu Fujii, et al. "Role of Nuclear Claudin-4 in Renal Cell Carcinoma." International Journal of Molecular Sciences 21, no. 21 (2020): 8340. http://dx.doi.org/10.3390/ijms21218340.

Full text

Abstract:

Claudin-4 (CLDN4) is a tight junction protein to maintain the cancer microenvironment. We recently reported the role of the CLDN4 not forming tight junction in the induction of epithelial-mesenchymal transition (EMT). Herein, we investigated the role of CLDN4 in renal cell carcinoma (RCC), focusing on CLDN4. CLDN4 expression in 202 RCCs was examined by immunostaining. CLDN4 phosphorylation and subcellular localization were examined using high metastatic human RCC SN12L1 and low metastatic SN12C cell lines. In 202 RCC cases, the CLDN4 expression decreased in the cell membrane and had no correla

APA, Harvard, Vancouver, ISO, and other styles

36

Chen, J., G. Sun, J. Liang, et al. "Comprehensive molecular characterization of TFE3-translocation renal cell carcinoma." European Urology 79 (June 2021): S750. http://dx.doi.org/10.1016/s0302-2838(21)00929-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Fok, Cynthia S., Maria M. Picken, Paul N. Meyer, Joseph I. Clark, Robert C. Flanigan, and Marcus L. Quek. "1308: XP11.2 Translocation Renal Cell Carcinoma in Adult Patients." Journal of Urology 177, no. 4S (2007): 430. http://dx.doi.org/10.1016/s0022-5347(18)31522-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Zhong, Minghao, Paul Weisman, Bing Zhu, et al. "Xp11.2 Translocation Renal Cell Carcinoma With PSF-TFE3 Rearrangement." Diagnostic Molecular Pathology 22, no. 2 (2013): 107–11. http://dx.doi.org/10.1097/pdm.0b013e318278962e.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Ahluwalia, Puneet, Balagopal Nair, and Ginil Kumar. "Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion: A Rare Case Report with Review of the Literature." Case Reports in Urology 2013 (2013): 1–4. http://dx.doi.org/10.1155/2013/810590.

Full text

Abstract:

Introduction. The recently recognized renal cell carcinomas associated with Xp11.2 translocations are rare tumors predominantly reported in children. Chromosome Xp11.2 translocation results in gene fusion related to transcription factor E3 (TFE3) that plays an important role in proliferation and survival.Case Report. Herein, we present two cases of a TFE3 translocation-associated RCC in young female adults, one detected incidentally and the other one presenting with gross hematuria. Tumor is characterized by immunohistochemistry and a literature review with optimal treatment regimen is present

APA, Harvard, Vancouver, ISO, and other styles

40

Carlo, Maria Isabel, Nabeela Khan, Yingbei Chen, et al. "The genomic landscape of metastatic non-clear cell renal cell carcinoma." Journal of Clinical Oncology 35, no. 6_suppl (2017): 474. http://dx.doi.org/10.1200/jco.2017.35.6_suppl.474.

Full text

Abstract:

474 Background: Non-clear cell renal cell carcinoma (nccRCC) encompasses about 20% of RCC cases and includes a number of subtypes that vary clinically and molecularly. Compared to ccRCC, these tumors have more limited sensitivity to conventional anti-VEGF agents and mTOR inhibitors, and there is clear need for better therapies. Analysis of genomic alterations in potentially targetable pathways may lead to novel therapeutic development strategies. Methods: We retrospectively analyzed tumors from 112 patients with metastatic nccRCC with targeted next-generation sequencing (NGS) across a panel of

APA, Harvard, Vancouver, ISO, and other styles

41

He, Huiying, Grace X. Zhou, Ming Zhou, and Longwen Chen. "The Distinction of Clear Cell Carcinoma of the Female Genital Tract, Clear Cell Renal Cell Carcinoma, and Translocation-Associated Renal Cell Carcinoma." International Journal of Gynecological Pathology 30, no. 5 (2011): 425–30. http://dx.doi.org/10.1097/pgp.0b013e318214dd4f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Pei, Jianming, Harry Cooper, Douglas B. Flieder, et al. "NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma." Modern Pathology 32, no. 5 (2019): 710–16. http://dx.doi.org/10.1038/s41379-018-0191-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Venyo, Anthony. "Anaplastic Lymphoma Kinase (ALK) Translocation Re-arrangement Renal Cell Carcinomas: A Review and Update of the Literature." International Journal of Clinical Case Reports and Reviews 3, no. 5 (2020): 01–13. http://dx.doi.org/10.31579/2690-4861/055.

Full text

Abstract:

Less than 50 cases of anaplastic lymphoma kinase (ALK) re-arrangement-associated renal cell carcinoma (ALK-RCC) been reported in the literature. ALK-RCC does affect children who have sickle cell trait and also adults with no evidence of sickle cell trait or sickle cell disease. ALK-RCC may be diagnosed incidentally or in individuals who have typical symptoms that simulate those or more common renal tumours.. Diagnosis of ALK-RCC does depend upon histopathology examination, immunohistochemistry studies as well as electron microscopy studies of nephrectomy / biopsy specimens of the kidney lesion

APA, Harvard, Vancouver, ISO, and other styles

44

Solano, Cristian, Shrinjaya Thapa, and Mohammad Muhsin Chisti. "Adult Xp11.2 translocation renal cell carcinoma managed effectively with pazopanib." BMJ Case Reports 14, no. 6 (2021): e243058. http://dx.doi.org/10.1136/bcr-2021-243058.

Full text

Abstract:

Xp11.2 translocation renal cell carcinoma (TRCC) is a rare and aggressive variant of renal cell carcinoma (RCC) when presenting in adults. We report a case of a man in his early 40s who was diagnosed with stage III Xp11.2 TRCC and underwent radical nephrectomy. Seven months following the surgery, an adrenal nodule and bilateral pulmonary nodules were discovered. He underwent cryoablation of the adrenal nodule and systemic treatment with daily pazopanib. He displayed stable disease for approximately 6 years. Following this period, multiple hospitalisations interrupted daily pazopanib therapy re

APA, Harvard, Vancouver, ISO, and other styles

45

Tan, Ayça, and Nalan Neşe. "MiT Family Translocation Renal Cell Carcinomas." Journal of Urological Surgery 3, no. 3 (2016): 108–9. http://dx.doi.org/10.4274/jus.1131.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Zhong, Minghao, Patricia De Angelo, Lisa Osborne, et al. "Translocation Renal Cell Carcinomas in Adults." American Journal of Surgical Pathology 36, no. 5 (2012): 654–62. http://dx.doi.org/10.1097/pas.0b013e31824f24a6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Malouf, Gabriel, Federico A. Monzon, Jerome Couturier, et al. "Genomic analysis of translocation renal cell carcinoma: Association of frequent 3p loss and poor outcome." Journal of Clinical Oncology 30, no. 5_suppl (2012): 360. http://dx.doi.org/10.1200/jco.2012.30.5_suppl.360.

Full text

Abstract:

360 Background: Translocation renal cell carcinoma (RCC) is a rare subtype of kidney cancer that is characterized by translocations involving TFEB or TFE3 genes. We recently reported that adults with translocation RCC have worse prognosis than pediatric and adolescent patients (Malouf et al, J Urol, 2011), however little is known about the genetic and epigenetic differences between these groups. Methods: Cytogenomic analysis was performed with 250K SNP microarrays (Affymetrix) on 19 tumor specimens of translocation RCC (Age <18 (n=6); Age >=18 (n=13) and 2 established cell lines (UOK109,

APA, Harvard, Vancouver, ISO, and other styles

48

Akhavein, Arash, Julia Han, Christopher Carter, Samer Z. Al-Quran, and Li-Ming Su. "Xp11 Translocation Renal Cell Carcinoma: Unusual Variant Masquerading as Upper Tract Urothelial Cell Carcinoma." Urology Case Reports 2, no. 3 (2014): 75–77. http://dx.doi.org/10.1016/j.eucr.2014.02.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Pipitone, Stefania, Maria Giuseppa Vitale, Cinzia Baldessari, Massimo Dominici, and Roberto Sabbatini. "Long survival of a young patient with Xp11.2 translocation metastatic clear cell renal carcinoma: case report." Tumori Journal 107, no. 6 (2021): NP131—NP135. http://dx.doi.org/10.1177/03008916211049275.

Full text

Abstract:

Introduction: Xp11.2 translocation is a rare subtype of renal cell carcinoma (RCC), identified as a single entity only from 2004 by World Health Organization (WHO). These tumors involve pediatric age group and rarely patients over 40 years old. Children show indolent disease; adult population has invasive tumor at diagnosis with rapid progression. Case report: We describe a case report of a young woman affected by metastatic clear cell renal carcinoma with Xp11.2 translocation. She achieved a longer stable disease (SD) to first line treatment with atezolizumab plus bevacizumab, obtaining a pro

APA, Harvard, Vancouver, ISO, and other styles

50

Khan, Iram, Sana Ghulam Nabi, Sajid Mushtaq, Noreen Akhtar, Usman Hassan, and Muddasir Hussain. "Morphological spectrum of Xp11. Translocation-Associated Renal Cell Carcinoma in a Developing Country." Pakistan Armed Forces Medical Journal 72, no. 5 (2022): 1629–35. http://dx.doi.org/10.51253/pafmj.v72i5.5942.

Full text

Abstract:

Objective: to determine unusual morphological features and a panel of immunohistochemical markers to diagnose Xp11 translocation carcinoma. Study Design: Retrospective longitudinal study. Place and Duration of Study: Shaukat Khanum Memorial Cancer Hospital, Lahore Pakistan, from Jun 2015 to Feb 2020. Methodoldogy: We analyzed clinicopathological features, and evaulated intensity and extent of TFE 3 immunoreactivity of 18 cases with suggested diagnosis of xp11 translocation associated renal cell carcinoma from 2015-2020. Results: Different morphological pattern includes

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!